Cargando…

Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia

ABSTRACT: OBJECTIVES: Patients with diabetes are at high risk for polypharmacy (ie, use of multiple medications) for treatment of diabetes, associated comorbidities and other coexisting conditions. This study aims to estimate the prevalence of polypharmacy and factors associated with polypharmacy am...

Descripción completa

Detalles Bibliográficos
Autores principales: Alwhaibi, Monira, Balkhi, Bander, Alhawassi, Tariq M, Alkofide, Hadeel, Alduhaim, Nouf, Alabdulali, Rawan, Drweesh, Hadeel, Sambamoorthi, Usha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988096/
https://www.ncbi.nlm.nih.gov/pubmed/29794097
http://dx.doi.org/10.1136/bmjopen-2017-020852
_version_ 1783329232523362304
author Alwhaibi, Monira
Balkhi, Bander
Alhawassi, Tariq M
Alkofide, Hadeel
Alduhaim, Nouf
Alabdulali, Rawan
Drweesh, Hadeel
Sambamoorthi, Usha
author_facet Alwhaibi, Monira
Balkhi, Bander
Alhawassi, Tariq M
Alkofide, Hadeel
Alduhaim, Nouf
Alabdulali, Rawan
Drweesh, Hadeel
Sambamoorthi, Usha
author_sort Alwhaibi, Monira
collection PubMed
description ABSTRACT: OBJECTIVES: Patients with diabetes are at high risk for polypharmacy (ie, use of multiple medications) for treatment of diabetes, associated comorbidities and other coexisting conditions. This study aims to estimate the prevalence of polypharmacy and factors associated with polypharmacy among adult patients with diabetes. METHODS: A cross-sectional retrospective observational study of adults with diabetes, who visited the outpatient clinic of a tertiary teaching hospital in Saudi Arabia, was conducted. Data were extracted from the Electronic Health Record database for a period of 12 months (January–December 2016). Polypharmacy was defined as the cumulative use of five or more medications. Polypharmacy among adults with diabetes was measured by calculating the average number of medications prescribed per patient. A multivariable logistic regression model was used to examine the factors associated with polypharmacy. RESULTS: A total of 8932 adults with diabetes were included in this study. Of these, nearly 78% had polypharmacy which was more likely among women as compared with men and more likely among older adults (age ≥60 years) as compared with the adults. Also, polypharmacy was two times as likely among patients with coexisting cardiovascular conditions (adjusted OR (AOR)=2.89; 95% CI 2.54 to 3.29), respiratory disease (AOR=2.42; 95% CI 1.92 to 3.03) and mental health conditions (AOR=2.19; 95% CI 1.74 to 2.76), and three times as likely among patients with coexisting musculoskeletal disease (AOR=3.16; 95% CI 2.31 to 4.30) as compared with those without these coexisting chronic conditions categories. CONCLUSIONS: Polypharmacy is common among patients with diabetes, with an even higher rate in older adults patients. Healthcare providers can help in detecting polypharmacy and in providing recommendations for simplifying medication regimens and minimising medications to enhance the outcome of diabetes care.
format Online
Article
Text
id pubmed-5988096
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-59880962018-06-07 Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia Alwhaibi, Monira Balkhi, Bander Alhawassi, Tariq M Alkofide, Hadeel Alduhaim, Nouf Alabdulali, Rawan Drweesh, Hadeel Sambamoorthi, Usha BMJ Open Pharmacology and Therapeutics ABSTRACT: OBJECTIVES: Patients with diabetes are at high risk for polypharmacy (ie, use of multiple medications) for treatment of diabetes, associated comorbidities and other coexisting conditions. This study aims to estimate the prevalence of polypharmacy and factors associated with polypharmacy among adult patients with diabetes. METHODS: A cross-sectional retrospective observational study of adults with diabetes, who visited the outpatient clinic of a tertiary teaching hospital in Saudi Arabia, was conducted. Data were extracted from the Electronic Health Record database for a period of 12 months (January–December 2016). Polypharmacy was defined as the cumulative use of five or more medications. Polypharmacy among adults with diabetes was measured by calculating the average number of medications prescribed per patient. A multivariable logistic regression model was used to examine the factors associated with polypharmacy. RESULTS: A total of 8932 adults with diabetes were included in this study. Of these, nearly 78% had polypharmacy which was more likely among women as compared with men and more likely among older adults (age ≥60 years) as compared with the adults. Also, polypharmacy was two times as likely among patients with coexisting cardiovascular conditions (adjusted OR (AOR)=2.89; 95% CI 2.54 to 3.29), respiratory disease (AOR=2.42; 95% CI 1.92 to 3.03) and mental health conditions (AOR=2.19; 95% CI 1.74 to 2.76), and three times as likely among patients with coexisting musculoskeletal disease (AOR=3.16; 95% CI 2.31 to 4.30) as compared with those without these coexisting chronic conditions categories. CONCLUSIONS: Polypharmacy is common among patients with diabetes, with an even higher rate in older adults patients. Healthcare providers can help in detecting polypharmacy and in providing recommendations for simplifying medication regimens and minimising medications to enhance the outcome of diabetes care. BMJ Publishing Group 2018-05-24 /pmc/articles/PMC5988096/ /pubmed/29794097 http://dx.doi.org/10.1136/bmjopen-2017-020852 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Pharmacology and Therapeutics
Alwhaibi, Monira
Balkhi, Bander
Alhawassi, Tariq M
Alkofide, Hadeel
Alduhaim, Nouf
Alabdulali, Rawan
Drweesh, Hadeel
Sambamoorthi, Usha
Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
title Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
title_full Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
title_fullStr Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
title_full_unstemmed Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
title_short Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
title_sort polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in saudi arabia
topic Pharmacology and Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988096/
https://www.ncbi.nlm.nih.gov/pubmed/29794097
http://dx.doi.org/10.1136/bmjopen-2017-020852
work_keys_str_mv AT alwhaibimonira polypharmacyamongpatientswithdiabetesacrosssectionalretrospectivestudyinatertiaryhospitalinsaudiarabia
AT balkhibander polypharmacyamongpatientswithdiabetesacrosssectionalretrospectivestudyinatertiaryhospitalinsaudiarabia
AT alhawassitariqm polypharmacyamongpatientswithdiabetesacrosssectionalretrospectivestudyinatertiaryhospitalinsaudiarabia
AT alkofidehadeel polypharmacyamongpatientswithdiabetesacrosssectionalretrospectivestudyinatertiaryhospitalinsaudiarabia
AT alduhaimnouf polypharmacyamongpatientswithdiabetesacrosssectionalretrospectivestudyinatertiaryhospitalinsaudiarabia
AT alabdulalirawan polypharmacyamongpatientswithdiabetesacrosssectionalretrospectivestudyinatertiaryhospitalinsaudiarabia
AT drweeshhadeel polypharmacyamongpatientswithdiabetesacrosssectionalretrospectivestudyinatertiaryhospitalinsaudiarabia
AT sambamoorthiusha polypharmacyamongpatientswithdiabetesacrosssectionalretrospectivestudyinatertiaryhospitalinsaudiarabia